At the 2014 Pharma Compliance Europe event, Michael Harris, Head of Enhanced Due Dilligance-EMEA, Thomson Reuters, gave the presentation "Effective third party due diligence for Pharma companies: understanding current trends and issues."
Harris explores in his presentation:
-
Who are we dealing with?
-
Detailed accurate reliable intelligence
-
Types of risks faced in the pharma and medical device industry in China
-
Corruption risks in China's pharma and medical device industry
-
Top countries for enhanced due diligence screening
-
Issues facing the pharma industry
-
What do you do to protect yourself?
-
Third party assessment
-
The basic questions
-
A structured risk based approach to due diligence
-
Penalties of getting it wrong
-
Conclusions